Overactive Bladder in the ElderlyA Guide to Pharmacological Management

被引：0
|
作者：
David R. Staskin
机构：
[1] New York Presbyterian Hospital,Department of Urology
[2] New York Presbyterian Hospital,Department of Urology, Weill Cornell Medical School
来源：
Drugs & Aging | 2005年 / 22卷
关键词：
Overactive Bladder; Oxybutynin; Urge Incontinence; Tolterodine; Solifenacin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Overactive bladder (OAB) is a common condition characterised by the symptoms of urinary frequency and urgency, with or without urge incontinence and nocturia. The prevalence of OAB increases markedly with age in both men and women. OAB can have a detrimental effect on physical functioning and psychological well-being, as well as significantly reducing quality of life.
引用
收藏
页码：1013 / 1028
页数：15
相关论文
共 50 条
  • [11] Pharmacological management of overactive bladder - A systematic and critical review of published economic evaluations
    Getsios, D
    El-Hadi, W
    Caro, I
    Caro, JJ
    PHARMACOECONOMICS, 2005, 23 (10) : 995 - 1006
  • [12] Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men
    De Nunzio, Cosimo
    Brucker, Benjamin
    Bschleipfer, Thomas
    Cornu, Jean-Nicolas
    Drake, Marcus J.
    Fusco, Ferdinando
    Gravas, Stavros
    Oelke, Matthias
    Peyronnet, Benoit
    Tutolo, Manuela
    van Koeveringe, Gommert
    Madersbacher, Stephan
    EUROPEAN UROLOGY, 2021, 79 (04) : 492 - 504
  • [13] Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence
    Zarowitz, Barbara J.
    Allen, Carrie
    O'Shea, Terrence
    Tangalos, Eric G.
    Berner, Todd
    Ouslander, Joseph G.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (11) : 2298 - 2307
  • [14] Pharmacological Treatment of overactive bladder for today and tomorrow
    Amarenco, G.
    Game, X.
    Haab, F.
    Cornu, J. -N.
    PROGRES EN UROLOGIE, 2016, 26 : S21 - S23
  • [15] Perspectives for the pharmacological treatment of overactive bladder syndrome
    Wrobel, Andrzej
    Kluz, Tomasz
    Surkont, Grzegorz
    Wlazlak, Edyta
    Miotla, Pawel
    Skorupska, Katarzyna
    Rechberger, Tomasz
    GINEKOLOGIA POLSKA, 2017, 88 (09) : 504 - 508
  • [16] Pharmacological treatment of overactive bladder in elderly patients
    Alcantara Montero, A.
    Brenes Bermudez, F. J.
    Fernandez Fernandez, L.
    Pascual Regueiro, N.
    MEDICINA DE FAMILIA-SEMERGEN, 2019, 45 (04): : E24 - E25
  • [17] Current and future pharmacological treatment for overactive bladder
    Yoshimura, N
    Chancellor, MB
    JOURNAL OF UROLOGY, 2002, 168 (05): : 1897 - 1913
  • [18] New pharmacological treatment concepts for overactive bladder
    Michel, MC
    UROLOGE A, 2003, 42 (06): : 807 - +
  • [19] ECONOMIC EVALUATION OF PHARMACOLOGICAL TREATMENTS FOR OVERACTIVE BLADDER
    Posnett, J.
    Walker, A.
    Nazir, J.
    Odeyemi, I. A. O.
    Hakimi, Z.
    Garnham, A.
    VALUE IN HEALTH, 2013, 16 (07) : A633 - A633
  • [20] Overview: Developments in the pharmacological therapy for overactive bladder
    Wein, Alan J.
    BJU INTERNATIONAL, 2006, 98 : 88 - 89
12345